Colossal: Building the Infrastructure for a New Era of Programmable Biology

Over the past several years, technology has continued to evolve at an alarmingly rapid rate. To this end, human beings are now able to adjust and accomplish things in entirely new ways that would have seemed ludicrous to even consider just a decade ago. Take, for example, the rise of Artificial Intelligence (AI), and the ways in which tools relating to it have been integrated into industries across the globe. Even just a few short years ago, the idea of an autonomous system filling out paperwork or auto-completing entire reports would’ve seemed like fodder for science-fiction novels. But here it is, in the real-world today, just a part of everyday life.

While AI has understandably garnered a lot of attention from the media, businesses, and the general public alike, it is far from the only such innovative technological advancement occurring on these fronts. The possibilities of new technological tools are expanding the boundaries of perception across multiple fields, and one example of this is the biological work that Colossal is pursuing.

Colossal is a company that is working to actively build the infrastructure for a new era of programmable biology. The company’s genome engineering, reproductive technologies, computational biology, and conservation work point toward a larger shift: biology moving from something humans primarily observe and protect to something they can increasingly understand, edit, restore, and deliberately engineer.

Understanding Biology

Biology is a key element of life. In many ways, biology can be thought of as the coding of the tactile world; the genome and DNA data that quite literally provide the infrastructure for organic constructions, such as the human body, animals, and beyond. For decades, scientists and academics have focused on studying biology, seeking to learn from it in invaluable ways. But today, equipped with new technology, a company like Colossal is doing far more than merely sitting on the sidelines and observing biology; they are actively engineering it. Advances in genome reading, writing, editing, and reproductive science are changing what conservation and species restoration can practically attempt.

Colossal’s work reflects a sizable shift occurring in the field as a whole. The company’s significance lies not simply in its ambition to bring back lost species, but in developing a broader genome-engineering pipeline capable of working with living cells and complex species.

Conservation and Restoration

One of the most popular and controversial topics of conversation relating to the modern engineering of biology is that of de-extinction. Through the use of these new tools and the augmentation of biology, the process of bringing extinct forms of life back into the real world is theoretically possible, and has been accomplished. However, there are several technical challenges involved that can produce tools with applications well beyond the resurrection of extinct animals.

Primarily, this is critical for Colossal’s work in how it relates to conservation. In many ways, conservation has become a proving ground for programmable biology; a way in which professionals can test out their various methods and demonstrate the potential merits.

What is a Civilization Technology?

A civilization technology is a foundational capability that operates at the scale of a whole society, becomes something many other industries depend on, and produces effects that are difficult to reverse. It overlaps with the economists’ concept of a general-purpose technology but is broader, taking in a technology’s effects on institutions, geopolitics, and daily life as well as productivity.

Colossal’s Achievements

The capability is the engineering of living systems, what Stanford’s Emerging Technology Review now calls biology as a general-purpose technology. Gene editing, synthetic biology and cheap DNA sequencing have turned biology from a science of observation into one of design.

Colossal has become best known for its work on de-extinction, but has built a larger genome-engineering pipeline that reads, writes, edits and assembles DNA and gets it into living cells, and applies it to conservation: a genetic-rescue effort for the critically endangered pink pigeon, work to engineer cane-toad-toxin resistance into Australia’s northern quoll, and reproductive technology aimed at the functionally extinct northern white rhino. In early 2025, it reached a $10.2 billion valuation.

The same pipeline that helps restore a species can, in principle, brew a medicine, grow a material, or make a crop survive a hotter climate. That is what distinguishes a general-purpose technology from a single industry, and it is why the field is beginning to draw the scale of capital and talent that once flowed almost entirely to software.

Why Programmable Biology?

A query often posed in relation to Colossal’s work is a simple one: why? In a world where traditional conservation efforts exist, what role does Colossal’s genome-rewriting actually play?

Today, traditional conservation can protect habitats and populations, but severe genetic bottlenecks, lost traits, reproductive barriers, and extremely small populations can require additional biological tools. Colossal’s work in engineering living systems introduces scientific, ecological, and ethical questions, but they are ones that the company is actively addressing through its work.

A Bold New Future

Moving forward, Colossal’s most important legacy may ultimately be the biological toolkit created while pursuing extraordinarily difficult species-restoration problems, and what those tools make possible for biodiversity in the future. Through these efforts, the company is contributing to the further development of programmable biology.